Sandoz Polska manufactures generic drugs and biosimilar biologics as part of Sandoz Global's pharmaceutical operations. The hiring profile is heavily sales-focused (12 of 19 roles), alongside targeted data and engineering work on ETL pipelines and Power BI dashboards — indicative of a mid-scale digital transformation effort. Active projects center on SAP S/4HANA migration, CMMS implementation, and demand-planning tool consolidation, suggesting operational maturity work rather than greenfield product development.
Sandoz Polska is a subsidiary of Sandoz Global, a major manufacturer of generic pharmaceuticals and biosimilar biologics. The organization operates across two primary business lines: generics (standard oral formulations and complex injectables, including respiratory therapeutics) and biosimilars (where Sandoz Global maintains global market position with eight marketed products and 24 molecules in development). The company is headquartered in Warsaw, Poland, and operates with 501–1,000 employees. Therapies developed by Sandoz serve approximately 500 million patients globally each year.
Sandoz Polska manufactures generic drugs (oral, injectable, and respiratory formulations) and biosimilar biologics. As a Sandoz Global subsidiary, it operates within two business divisions: Generics and Biosimilars, serving healthcare systems worldwide.
Yes. Sales roles represent the largest hiring segment: 12 of 19 active positions, with most at mid-level seniority. All roles are based in Poland, and hiring velocity is accelerating.
Core systems include SAP S/4HANA, GCP, SQL, Power BI, and Qlik Sense for analytics. The company also uses HPLC, Kinaxis, and Power Query. Current projects focus on SAP S/4HANA migration and ETL/ELT pipeline optimization.
Other companies in the same industry, closest in size